19th Feb 2025 07:00
Commercial International Bank (Egypt) S.A.E. |
Consolidated Financial Statements - IFRS December 31, 2024
|
Consolidated Income Statement for the Year Ended December 31, 2024 |
| ||||||
Notes | Dec. 31, 2024 |
| Dec. 31, 2023 | ||||
|
| ||||||
|
| ||||||
Interest and similar income | 182,735,474 |
| 104,028,379 | ||||
Interest and similar expense |
| (91,751,450) | (51,142,688) | ||||
Net interest income | 3 | 90,984,024 |
|
| 52,885,691 | ||
|
| ||||||
Fee and commission income | 12,813,876 |
| 9,049,924 | ||||
Fee and commission expense |
| (5,728,656) | (3,611,699) | ||||
Net fee and commission income | 4 | 7,085,220 |
|
| 5,438,225 | ||
|
| ||||||
Dividend income | 5 | 195,047 |
| 234,010 | |||
Net trading income | 6 | 20,470,230 |
| 4,006,880 | |||
Gain on investments | 20 | 459,337 |
| 221,810 | |||
Intangible assets | - |
| (51,831) | ||||
Goodwill | - |
| (206,287) | ||||
Administrative expenses | 7 | (19,952,958) |
| (13,299,910) | |||
Other operating expenses | 8 | (23,201,267) |
| (6,341,869) | |||
Impairment charges for credit losses | 9 | (4,523,819) |
| (4,270,081) | |||
Bank's share in the loss of associates | 12 | (17,786) | (55,983) | ||||
Profit before income tax from continuing operations |
| 71,498,028 | 38,560,655 | ||||
|
| ||||||
Taxes | 10 | (21,878,946) |
| (11,942,406) | |||
|
|
| |||||
Net profit from continued operations |
| 49,619,082 | 26,618,249 | ||||
|
| ||||||
Discontinued Operations |
|
|
| ||||
Net (loss) from discontinued operations | 44 | - | (42,102) | ||||
Net profit for the Year |
| 49,619,082 | 26,576,147 | ||||
Attributable to: |
|
|
| ||||
Equity holders of the parent | 49,558,744 |
| 26,541,824 | ||||
Non-controlling interest |
| 60,338 |
|
| 34,323 | ||
Net Profit for the year |
| 49,619,082 |
|
| 26,576,147 | ||
|
| ||||||
|
| ||||||
|
| ||||||
Earnings per share | 11 |
|
| ||||
Basic attributable to equity holders of the parent | 16.34 |
| 8.75 | ||||
Diluted attributable to equity holders of the parent | 16.14 |
| 8.64 | ||||
The accompying notes from 1 to 44 form an integral part of these consolidated financial statements. |
|
Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2024 |
| ||||||||
Dec. 31, 2024 |
| Dec. 31, 2023 | |||||||
|
| ||||||||
Profit for the year |
| 49,619,082 | 26,618,249 | ||||||
|
| ||||||||
Comprehensive income items that will not be reclassified to the profit or loss: |
|
|
| ||||||
Change in fair value of equity instruments measured at fair value through comprehensive income | 51,159 |
| 259,291 | ||||||
Deferred Tax impact for investments that will not be reclassified to P&L | (157,217) |
| (131,008) | ||||||
Transferred to RE from financial assets at fair value through comprehensive income | (370,224) |
| (95,308) | ||||||
Comprehensive income items that is or may be reclassified to the profit or loss: |
|
|
| ||||||
Change in fair value of Financial invesments measured at fair value through comprehensive income | 8,634,672 |
| (7,070,544) | ||||||
Change in fair value from selling FVOCI financial instruments | (459,337) |
| (205,344) | ||||||
Cumulative foreign currencies translation differences | 989,367 |
| (32,971) | ||||||
Deferred Tax impact for investments that may be reclassified to P&L | 887,145 |
| 1,530,823 | ||||||
Effect of ECL in fair value of debt instruments measured at fair value through OCI | 936,949 |
|
| 1,888,326 | |||||
Total comprehensive income for the year | 60,131,596 |
|
| 22,761,514 | |||||
|
| ||||||||
As follows: |
|
|
| ||||||
Equity holders of the parent | 60,071,258 |
| 22,727,191 | ||||||
Non-controlling interest | 60,338 |
|
| 34,323 | |||||
Total comprehensive income for the year | 60,131,596 |
|
| 22,761,514 | |||||
Consolidated Statement of Financial Position as at December 31, 2024 |
| ||||
Notes | Dec. 31, 2024 |
| Dec. 31, 2023 | ||
|
| ||||
Assets |
|
|
| ||
Cash and balances at the central bank | 13 | 136,531,020 |
| 71,887,821 | |
Due from banks | 14 | 270,829,834 |
| 231,085,244 | |
Loans and advances to banks, net | 15 | 9,555,410 |
| 822,448 | |
Loans and advances to customers, net | 16 | 343,542,674 |
| 234,985,936 | |
Financial Assets at fair value through profit or loss | 19 | 380,769 |
| 306,375 | |
Derivative financial instruments | 17 | 819,711 |
| 1,105,148 | |
Financial Assets at fair value through OCI | 19 | 234,694,966 |
| 233,430,236 | |
Financial Assets at amortized cost | 19 | 168,118,219 |
| 38,341,019 | |
Right of use assets | 23 | 1,301,850 |
| 729,823 | |
Investments in associates | 21 | 98,193 |
| 115,979 | |
Non current assets held for sale | 42 | - |
| 161 | |
Other assets | 22 | 44,282,773 |
| 18,801,444 | |
Deferred tax assets | 10.2 | 2,685,330 |
| 1,685,230 | |
Property and equipment | 23 | 3,997,929 | 2,739,092 | ||
Total assets |
| 1,216,838,678 |
| 836,035,956 | |
Liabilities and equity |
|
|
| ||
Liabilities |
|
|
| ||
Due to banks | 24 | 2,034,885 |
| 12,458,003 | |
Due to customers | 25 | 972,595,958 |
| 677,237,479 | |
Lease liabilities | 23 | 1,425,604 |
| 674,417 | |
Derivative financial instruments | 17 | 100,571 |
| 140,934 | |
Non current liabilities held for sale | 43 | 1,397 |
| 873 | |
Issued debt instruments | 18 | 5,067,781 |
| 3,073,349 | |
Other liabilities | 27 | 27,725,569 |
| 21,937,452 | |
Current Tax liability | 18,327,968 |
| 9,395,534 | ||
Other loans | 26 | 23,962,389 |
| 12,483,907 | |
Provisions | 28 | 18,623,634 | 11,095,996 | ||
Total liabilities |
| 1,069,865,756 | 748,497,944 | ||
Equity |
|
|
| ||
Issued and paid in capital | 29 | 30,431,580 |
| 30,195,010 | |
Reserves | 30 | 62,899,966 |
| 28,362,690 | |
Reserve for employee stock ownership plan (ESOP) | 30 | 1,868,235 |
| 1,486,010 | |
Retained earnings | 30 | 51,590,097 | 27,334,229 | ||
Total equity attributable to equity holders of the parent |
| 146,789,878 | 87,377,939 | ||
Non-controlling interest | 38 | 183,044 |
| 160,073 | |
Total equity | 146,972,922 | 87,538,012 | |||
Total liabilities and equity | 1,216,838,678 | 836,035,956 | |||
The accompying notes from 1 to 44 form an integral part of these consolidated financial statements. |
| ||||
Consolidated Statement of Changes in Shareholders' Equity | |||||||||||
| |||||||||||
Dec. 31, 2023 | Issued and paid in capital | Reserve for employee stock ownership plan (ESOP) | Retained earnings | Reserves | Total | Non-controlling interest | Total equity | ||||
Beginning balance | 29,825,134 | 1,895,435 | 15,144,290 | 19,342,866 | 66,207,725 | 580,431 | 66,788,156 | ||||
Change in non controlling interest from acquisition of subsidiaries | - | - | - | - | - | (536,867) | (536,867) | ||||
Net Profit for the year | - | - | 26,541,824 | - | 26,541,824 | 34,323 | 26,576,147 | ||||
Capital increase | 369,876 | - | - | - | 369,876 | - | 369,876 | ||||
Reserve for employee stock ownership plan (ESOP) | - | 754,817 | - | - | 754,817 | - | 754,817 | ||||
Dividend | - | - | (2,016,159) | - | (2,016,159) | (17,108) | (2,033,267) | ||||
Transferred to reserves | - | (1,164,242) | (12,335,726) | 9,019,824 | (4,480,144) | 99,294 | (4,380,850) | ||||
Balance at 31 December 2023 | 30,195,010 | 1,486,010 | 27,334,229 | 28,362,690 | 87,377,939 | 160,073 | 87,538,012 |
| |||
Dec. 31, 2024 |
| ||||||||||
Beginning balance | 30,195,010 | 1,486,010 | 27,334,229 | 28,362,690 | 87,377,939 | 160,073 | 87,538,012 |
| |||
Net Profit for the year | - | - | 49,558,744 | - | 49,558,744 | 60,338 | 49,619,082 |
| |||
Capital increase | 236,570 | - | - | - | 236,570 | - | 236,570 |
| |||
Reserve for employee stock ownership plan (ESOP) | - | 1,005,350 | - | - | 1,005,350 | - | 1,005,350 |
| |||
Dividend | - | - | (2,379,819) | - | (2,379,819) | (37,367) | (2,417,186) |
| |||
Transferred to reserves | - | (623,125) | (22,923,057) | 34,537,276 | 10,991,094 | - | 10,991,094 |
| |||
Balance at 31 December 2024 | 30,431,580 | 1,868,235 | 51,590,097 | 62,899,966 | 146,789,878 | 183,044 | 146,972,922 |
| |||
Consolidated Statement of Cash Flow for the Year Ended December 31, 2024 | ||||
| ||||
Notes | Dec. 31, 2024 |
| Dec. 31, 2023 | |
|
| |||
|
| |||
Cash flow from operating activities |
|
| ||
Profit before income tax from continued operations |
| 71,498,028 |
| 38,560,655 |
(Loss) from discontinued operations |
| - |
| (42,102) |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |
Fixed assets depreciation | 1,414,920 |
| 788,209 | |
Impairment charge for credit losses (Loans and advances to customers) | 4,768,107 |
| 2,311,867 | |
Other provisions release/charge | 3,363,525 |
| 2,821,141 | |
Impairment release/charge for credit losses (due from banks) | (341) |
| (47,234) | |
Impairment release/charge for credit losses (financial investments) | (243,947) |
| 2,005,448 | |
Impairment release/charge for other assets | 37,939 |
| 17,620 | |
Exchange revaluation differences for financial assets at fair value through OCI and AC | (21,026,044) |
| (5,442,433) | |
Utilization of other provisions | (9,586) |
| (5,850) | |
Revaluation differences impairment charge for due from banks | 2,008 |
| - | |
Impairment of goodwill and intangible assets | - |
| 258,118 | |
Exchange revaluation differences of other provisions | 4,173,699 |
| 1,213,126 | |
Revaluation differences impairment charge for Financial Assets at Amortized cost | 119,504 |
| 607 | |
Impairment (Reversal of impairment) charges of investments in associates | - |
| (9,000) | |
Profits from selling property, plant and equipment | (2,246) |
| (1,663) | |
Profits/losses from selling financial investments at fair value through OCI | (459,337) |
| (205,344) | |
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | 1,329,905 |
| 1,903 | |
Shares based payments | 1,005,350 |
| 754,817 | |
Losses (Profits) from selling investments in associates | - |
| (7,466) | |
Bank's share in the profits / losses of associates | 17,786 |
| 55,983 | |
Operating profits before changes in working capital |
| 65,989,270 |
| 43,028,402 |
|
| |||
Net decrease (increase) in working capital |
|
|
| |
Due from banks | (111,192,809) |
| 18,441,280 | |
Financial assets at fair value through profit or loss | (74,394) |
| - | |
Derivative financial instruments | 490,593 |
| 755,995 | |
Loans and advances to banks and customers | (122,049,597) |
| (41,467,103) | |
Other assets | (22,078,200) |
| (3,968,123) | |
Non current assets held for sale | - |
| (161) | |
Non current liabilities held for sale | 524 |
| 873 | |
Due to banks | (10,423,118) |
| 8,961,305 | |
Due to customers | 295,358,479 |
| 145,620,929 | |
Current income tax obligations paid | (5,220,965) |
| (3,704,414) | |
Other liabilities | 5,788,117 | 4,236,973 | ||
Net cash generated from operating activities |
| 96,587,900 |
| 171,905,956 |
|
| |||
Net cash generated from (used in) operating activities |
|
|
| |
|
| |||
Cash flow from investing activities |
|
|
| |
Proceeds from sale of investments in associates | 11,956 |
| 4,510 | |
Payments for purchases of property, equipment and branches construction | (6,707,018) |
| (1,685,846) | |
Proceeds from selling property and equipment | 2,246 |
| 1,663 | |
Proceeds from redemption of financial assets at amortized cost | 2,028,180 |
| 6,125,452 | |
Payments for purchases of financial assets at amortized cost | (129,153,136) |
| (9,290,232) | |
Payments for purchases of financial assets at fair value through OCI | (113,445,585) |
| (129,073,519) | |
Proceeds from selling financial assets at fair value through OCI | 140,381,225 |
| 102,763,650 | |
Payment for investment in subsidiaries | - | (1,142,840) | ||
Net cash generated from (used in) investing activities |
| (106,882,132) |
| (32,297,162) |
|
|
| ||
|
| |||
Cash flow from financing activities |
|
|
| |
Other loans |
| 11,478,482 |
| 4,504,932 |
Other loans - new loans obtained in the year | 3,835,016 | 9,604,139 | ||
Other loans - loans repaid in the year | (243,015) | (5,334,093) | ||
Other loans - movement in foreign exchange rate | 7,886,481 | 234,886 | ||
Dividends paid | (2,379,819) |
| (2,016,159) | |
Issued debt instruments | 1,994,432 |
| 616,742 | |
Cash payments for lease (principle and interest) | (501,724) |
| (248,871) | |
Capital increase | 236,570 | 369,876 | ||
Net cash generated from (used in) financing activities |
| 10,827,941 |
| 3,226,520 |
|
| |||
|
| |||
Net (decrease) increase in cash and cash equivalent during the year | 533,709 |
| 142,835,314 | |
Beginning balance of cash and cash equivalent | 225,941,383 | 83,106,069 | ||
Cash and cash equivalent at the end of the year |
| 226,475,092 |
| 225,941,383 |
|
| |||
Cash and cash equivalent at the end of the year |
|
|
| |
Cash and balances at the central bank | 13 | 136,531,020 |
| 71,887,821 |
Due from banks with maturities of 3 months or less | 14 | 203,103,430 |
| 217,156,599 |
Treasury bills and other governmental notes with maturities of three months or less | 19 | 1,618,665 |
| 1,293,148 |
Obligatory reserve balance with CBE | 13 | (114,778,023) | (64,396,185) | |
Total cash and cash equivalent | 31 | 226,475,092 |
| 225,941,383 |
Related Shares:
Com.int.bk.regs